The company said it received notice on January 1 from the FDA’s Center for Veterinary Medicine that the funding will support its ongoing effectiveness study of Canalevia-CA1
Our scientists found that toxicological data for most PFAS are incomplete or unavailable, leaving significant uncertainty about consumer safety
Elanco expects Befrena to launch in the US in the first half of 2026
Biotium reports that GlycoLiner Labelling is fully covalent and compatible with standard fixation and permeabilization protocols
The company’s consolidated revenue from operations rose to Rs. 361.13 crore in Q2 FY26 and Rs. 707.67 crore for the first half
Once finalized, cough syrups will no longer be available for over-the-counter sale
The trials did not show a statistically significant reduction in annualized clinical fracture rates compared to placebo or bisphosphonates
The applications aim to launch Phase Ib/II trials for relapsed/refractory multiple myeloma and primary plasma cell leukemia, respectively
The company views ESG reporting as a strategic tool to build trust with clients, investors, regulators, and stakeholders worldwide
Intas becomes the first and only company in India to offer IVF and gynecology therapies with needle-free injections
Subscribe To Our Newsletter & Stay Updated
